• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在 1 型糖尿病合并新发生微量白蛋白尿的患者中,晚期慢性肾脏病的发展可能不需要进展到蛋白尿。

In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.

机构信息

Division of Endocrinology, University of Toronto, Toronto, Ontario, Canada.

出版信息

Kidney Int. 2010 Jan;77(1):57-64. doi: 10.1038/ki.2009.399.

DOI:10.1038/ki.2009.399
PMID:19847154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3725722/
Abstract

We sought to study new-onset microalbuminuria, its progression, and the decline of renal function in patients with type 1 diabetes. Using a cohort of 109 patients who developed new-onset microalbuminuria in the first 4 years following enrollment in the 1st Joslin Kidney Study, we simultaneously tracked the change in their renal function and urinary albumin excretion. Of these, 79 patients were followed for an average of 12 years after microalbuminuria onset, wherein their glomerular filtration rate was estimated by the Modification of Diet in Renal Disease Study formula and compared with their microalbuminuria and proteinuria. The concordance between these outcomes was weak. Only 12 of the 23 patients who progressed to advanced (stage 3-5) chronic kidney disease developed proteinuria, which, in general, did not precede but accompanied the progression to advanced chronic kidney disease. The remaining 11 patients who developed advanced disease had persistent microalbuminuria or returned to normal albuminuria. Thus, we found that one-third of patients with type 1 diabetes developed advanced chronic kidney disease relatively soon after the onset of microalbuminuria and this was not conditional on the presence of proteinuria. Contrary to the existing concept of early nephropathy in type 1 diabetes, less emphasis should be placed on the mechanisms of progression to proteinuria and more placed on mechanisms initiating and promoting the early decline of renal function that eventually progresses to advanced chronic kidney disease.

摘要

我们旨在研究 1 型糖尿病患者中新发微量白蛋白尿的发生、进展以及肾功能下降情况。本研究纳入了 109 名在第 1 次 Joslin 肾脏研究入组后 4 年内发生新发微量白蛋白尿的患者,我们同步追踪了他们的肾功能和尿白蛋白排泄变化。其中,79 名患者在微量白蛋白尿发病后平均随访 12 年,在此期间,我们采用肾脏病饮食改良研究公式估计了他们的肾小球滤过率,并将其与微量白蛋白尿和蛋白尿进行了比较。这些结果之间的一致性较弱。在进展为晚期(3-5 期)慢性肾脏病的 23 名患者中,仅有 12 名患者出现蛋白尿,一般来说,蛋白尿并没有先于进展为晚期慢性肾脏病,而是伴随其发生。其余 11 名进展为晚期疾病的患者一直存在微量白蛋白尿或恢复至正常白蛋白尿。因此,我们发现,1/3 的 1 型糖尿病患者在微量白蛋白尿发生后不久就会发展为晚期慢性肾脏病,而且这并不取决于蛋白尿的存在。与 1 型糖尿病早期肾病的现有概念相反,应该较少关注向蛋白尿进展的机制,而更多地关注启动和促进最终进展为晚期慢性肾脏病的早期肾功能下降的机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c825/3725722/d13d19424836/nihms493137f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c825/3725722/7a4bb4db8ce1/nihms493137f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c825/3725722/d13d19424836/nihms493137f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c825/3725722/7a4bb4db8ce1/nihms493137f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c825/3725722/d13d19424836/nihms493137f2.jpg

相似文献

1
In patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria.在 1 型糖尿病合并新发生微量白蛋白尿的患者中,晚期慢性肾脏病的发展可能不需要进展到蛋白尿。
Kidney Int. 2010 Jan;77(1):57-64. doi: 10.1038/ki.2009.399.
2
Comments on 'in patients with type 1 diabetes and new-onset microalbuminuria the development of advanced chronic kidney disease may not require progression to proteinuria'.对“在1型糖尿病和新发微量白蛋白尿患者中,晚期慢性肾脏病的发展可能无需进展为蛋白尿”的评论
Kidney Int. 2010 Nov;78(10):1049; author reply 1049. doi: 10.1038/ki.2010.300.
3
Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes.进行性肾脏衰退:1型糖尿病中糖尿病肾病的新范式
Diabetes Care. 2015 Jun;38(6):954-62. doi: 10.2337/dc15-0184.
4
Time to abandon microalbuminuria?是时候摒弃微量白蛋白尿了吗?
Kidney Int. 2006 Oct;70(7):1214-22. doi: 10.1038/sj.ki.5001729. Epub 2006 Jul 26.
5
Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.1型糖尿病患者接受血管紧张素转换酶抑制剂治疗后,从微量白蛋白尿进展为蛋白尿的决定因素。
Clin J Am Soc Nephrol. 2007 May;2(3):461-9. doi: 10.2215/CJN.03691106. Epub 2007 Mar 27.
6
Systematic review on urine albumin testing for early detection of diabetic complications.关于尿白蛋白检测用于早期发现糖尿病并发症的系统评价。
Health Technol Assess. 2005 Aug;9(30):iii-vi, xiii-163. doi: 10.3310/hta9300.
7
Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.非白蛋白尿性慢性肾脏病向终末期肾病进展的风险:CRIC(慢性肾功能不全队列)研究。
Am J Kidney Dis. 2018 Nov;72(5):653-661. doi: 10.1053/j.ajkd.2018.02.364. Epub 2018 May 18.
8
Persistent renal hypertrophy and faster decline of glomerular filtration rate precede the development of microalbuminuria in type 1 diabetes.持续性肾肥大和肾小球滤过率更快下降先于1型糖尿病患者微量白蛋白尿的发生。
Diabetes. 2006 Sep;55(9):2620-5. doi: 10.2337/db06-0592.
9
Effect of captopril on progression to clinical proteinuria in patients with insulin-dependent diabetes mellitus and microalbuminuria. European Microalbuminuria Captopril Study Group.卡托普利对胰岛素依赖型糖尿病合并微量白蛋白尿患者进展为临床蛋白尿的影响。欧洲微量白蛋白尿卡托普利研究组。
JAMA. 1994 Jan 26;271(4):275-9.
10
The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus.老年糖尿病患者中微量白蛋白尿和大量蛋白尿与心血管疾病死亡率的相关性
Arch Intern Med. 2000 Apr 24;160(8):1093-100. doi: 10.1001/archinte.160.8.1093.

引用本文的文献

1
Urinary plasminogen as an early marker of diabetic kidney disease in children with type 1 diabetes mellitus: a cross-sectional study.尿纤溶酶原作为1型糖尿病儿童糖尿病肾病的早期标志物:一项横断面研究
Eur J Pediatr. 2025 Jun 27;184(7):451. doi: 10.1007/s00431-025-06278-3.
2
UKB-MDRMF: a multi-disease risk and multimorbidity framework based on UK biobank data.英国生物银行多疾病风险与共病框架(UKB-MDRMF):基于英国生物银行数据的多疾病风险与共病框架
Nat Commun. 2025 Apr 22;16(1):3767. doi: 10.1038/s41467-025-58724-3.
3
Early Detection of Diabetic Nephropathy Based on Urinary and Serum Biomarkers: An Updated Systematic Review.

本文引用的文献

1
Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial.替米沙坦、雷米普利或二者联用对高血管风险人群的肾脏结局影响(ONTARGET研究):一项多中心、随机、双盲、对照试验
Lancet. 2008 Aug 16;372(9638):547-53. doi: 10.1016/S0140-6736(08)61236-2.
2
Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study.一项关于儿童期发病的1型糖尿病队列中微量白蛋白尿及进展为大量白蛋白尿风险的前瞻性观察研究。
BMJ. 2008 Mar 29;336(7646):697-701. doi: 10.1136/bmj.39478.378241.BE. Epub 2008 Mar 18.
3
基于尿液和血清生物标志物的糖尿病肾病早期检测:一项更新的系统评价
Adv Biomed Res. 2024 Oct 28;13:104. doi: 10.4103/abr.abr_461_23. eCollection 2024.
4
A comprehensive review of biomarker research in diabetic nephropathy from a global bibliometric and visualization perspective.从全球文献计量学和可视化角度全面综述糖尿病肾病的生物标志物研究。
Medicine (Baltimore). 2024 Nov 29;103(48):e40729. doi: 10.1097/MD.0000000000040729.
5
Diagnostic Performance of Cystatin C in the Early Detection of Diabetic Kidney Disease at the University of Nigeria Teaching Hospital, Ituku-Ozalla.尼日利亚大学教学医院(伊图库-奥扎拉)胱抑素C在糖尿病肾病早期检测中的诊断效能
Cureus. 2024 Oct 23;16(10):e72230. doi: 10.7759/cureus.72230. eCollection 2024 Oct.
6
Association of variants in AGTR1, ACE, MTHFR genes with microalbuminuria and risk factors for the onset of diabetic nephropathy in adolescents with type 1 diabetes in the population of Serbia.塞尔维亚 1 型糖尿病青少年人群中 AGTR1、ACE、MTHFR 基因变异与微量白蛋白尿及糖尿病肾病发病危险因素的相关性。
PLoS One. 2024 Oct 24;19(10):e0312489. doi: 10.1371/journal.pone.0312489. eCollection 2024.
7
Development of a time-resolved immunochromatographic test strip for rapid and quantitative determination of retinol-binding protein 4 in urine.研制一种时间分辨免疫层析测试条,用于快速定量检测尿液中的视黄醇结合蛋白 4。
Mikrochim Acta. 2024 May 8;191(6):311. doi: 10.1007/s00604-024-06381-6.
8
Urinary Vitamin D Binding Protein: A Marker of Kidney Tubular Dysfunction in Patients at Risk for Type 2 Diabetes.尿维生素D结合蛋白:2型糖尿病高危患者肾小管功能障碍的标志物。
J Endocr Soc. 2024 Jan 31;8(3):bvae014. doi: 10.1210/jendso/bvae014. eCollection 2024 Jan 16.
9
The relevance of the non-invasive biomarkers lncRNA GAS5/miR-21 ceRNA regulatory network in the early identification of diabetes and diabetic nephropathy.非侵入性生物标志物lncRNA GAS5/miR-21 ceRNA调控网络在糖尿病及糖尿病肾病早期诊断中的相关性
Diabetol Metab Syndr. 2023 Oct 11;15(1):197. doi: 10.1186/s13098-023-01179-7.
10
Prevalence of Diabetic Kidney Disease with Different Subtypes in Hospitalized Patients with Diabetes and Correlation Between eGFR and LncRNA XIST Expression in PBMCs.糖尿病住院患者中不同亚型糖尿病肾病的患病率及外周血单个核细胞中估算肾小球滤过率与长链非编码RNA XIST表达的相关性
Diabetes Ther. 2023 Sep;14(9):1549-1561. doi: 10.1007/s13300-023-01439-9. Epub 2023 Jul 9.
Serial measurements of cystatin C are more accurate than creatinine-based methods in detecting declining renal function in type 1 diabetes.
在检测1型糖尿病患者肾功能下降方面,连续测量胱抑素C比基于肌酐的方法更准确。
Diabetes Care. 2008 May;31(5):971-3. doi: 10.2337/dc07-1588. Epub 2008 Mar 4.
4
Lowering of proteinuria in response to antihypertensive therapy predicts improved renal function in late but not in early diabetic nephropathy: a pooled analysis.降压治疗后蛋白尿的降低预示着晚期而非早期糖尿病肾病患者肾功能的改善:一项汇总分析。
Am J Nephrol. 2008;28(4):614-27. doi: 10.1159/000117461. Epub 2008 Feb 19.
5
Sequence of progression of albuminuria and decreased GFR in persons with type 1 diabetes: a cohort study.1型糖尿病患者蛋白尿进展及肾小球滤过率降低的序列:一项队列研究。
Am J Kidney Dis. 2007 Nov;50(5):721-32. doi: 10.1053/j.ajkd.2007.08.005.
6
Determinants of progression from microalbuminuria to proteinuria in patients who have type 1 diabetes and are treated with angiotensin-converting enzyme inhibitors.1型糖尿病患者接受血管紧张素转换酶抑制剂治疗后,从微量白蛋白尿进展为蛋白尿的决定因素。
Clin J Am Soc Nephrol. 2007 May;2(3):461-9. doi: 10.2215/CJN.03691106. Epub 2007 Mar 27.
7
Microalbuminuria and the risk for early progressive renal function decline in type 1 diabetes.1型糖尿病中的微量白蛋白尿与早期肾功能进行性下降风险
J Am Soc Nephrol. 2007 Apr;18(4):1353-61. doi: 10.1681/ASN.2006080872. Epub 2007 Feb 28.
8
Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate.在肾脏病饮食改良研究方程中使用标准化血清肌酐值来估算肾小球滤过率。
Ann Intern Med. 2006 Aug 15;145(4):247-54. doi: 10.7326/0003-4819-145-4-200608150-00004.
9
Estimating glomerular filtration rate in diabetes: a comparison of cystatin-C- and creatinine-based methods.糖尿病患者肾小球滤过率的估算:基于胱抑素C和肌酐方法的比较
Diabetologia. 2006 Jul;49(7):1686-9. doi: 10.1007/s00125-006-0275-7. Epub 2006 May 3.
10
The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study.年轻1型糖尿病患者微量白蛋白尿与肾小球滤过率的关系:牛津地区前瞻性研究。
Kidney Int. 2005 Oct;68(4):1740-9. doi: 10.1111/j.1523-1755.2005.00590.x.